MS Drug Costs Skyrocket After Medicare Rule Change: Study

WEDNESDAY, Feb. 6, 2019 — Medicare rule changes could trigger a spike in out-of-pocket drug costs for patients with multiple sclerosis (MS).
Due to rules that restrict access and require patients to cover more of the cost, those without low-income…
Source: Topamax